Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation

References

• HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
   PubMed Web of Science ®Google Scholar
• MiravitllesMCalleMSoler-CataluñaJJClinical phenotypes of COPD. Identification, definition and implications for guidelinesArch Bronconeumol201248869822196477
   PubMed Web of Science ®Google Scholar
• DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet20123791341135122314182
   PubMed Web of Science ®Google Scholar
• GarchaDSThurstonSJPatelARChanges in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPDThorax2012671075108022863758
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med201118466267121680942
   PubMed Web of Science ®Google Scholar
• MiravitllesMEspinosaCFernández-LasoEStudy Group of Bacterial Infection in COPDRelationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPDChest1999116404610424501
   PubMed Web of Science ®Google Scholar
• GeorgeSNGarchaDSMackayAJHuman rhinovirus infection during naturally occurring COPD exacerbationsEur Respir J201444879624627537
   PubMed Web of Science ®Google Scholar
• MalliaPMessageSDGielenVExperimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationAm J Respir Crit Care Med201118373474220889904
   PubMed Web of Science ®Google Scholar
• MolyneauxPLMalliaPCoxMJOutgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20131881224123123992479
   PubMed Web of Science ®Google Scholar
• MatkovicZMiravitllesMChronic bronchial infection in COPD. Is there an infective phenotype?Respir Med2013107102223218452
   PubMed Web of Science ®Google Scholar
• Martínez-GarcíaMASoler-CataluñaJJDonat SanzYFactors associated with bronchiectasis in chronic obstructive pulmonary disease patientsChest20111401130113721546440
   PubMed Web of Science ®Google Scholar
• MiravitllesMAnzuetoAAntibiotic prophylaxis in COPD: why, when, and for whom?Pulm Pharmacol Ther20153211912324825753
   PubMed Web of Science ®Google Scholar
• SpagnoloPFabbriLMBushALong-term macrolide treatment for chronic respiratory diseaseEur Respir J20134223925123180583
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCCOPD Clinical Research NetworkAzithromycin for prevention of exacerbations of COPDN Engl J Med201136568969821864166
   PubMed Web of Science ®Google Scholar
• HanMKTayobNMurraySPredictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapyAm J Respir Crit Care Med20141891503150824779680
   PubMed Web of Science ®Google Scholar
• UzunSDjaminRSKluytmansJAAzithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trialLancet Respir Med2014236136824746000
   PubMed Web of Science ®Google Scholar
• SethiSJonesPWTheronMSPULSE Study GroupPulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialRespir Res2010111020109213
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish Society of Pulmonology and Thoracic SurgerySpanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic SurgeryArch Bronconeumol20124824725722561012
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• BarnesPJShapiroSDPauwelsRAChronic obstructive pulmonary disease: molecular and cellular mechanismsEur Respir J20032267268814582923
   PubMed Web of Science ®Google Scholar
• BarnesPJHanselTTProspects for new drugs for chronic obstructive pulmonary diseaseLancet200436498599615364192
   PubMed Web of Science ®Google Scholar
• RutgersSRPostmaDSten HackenNHOngoing airway inflammation in patients with COPD who do not currently smokeThorax200055121810607796
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
   PubMed Web of Science ®Google Scholar
• StănescuDSannaAVeriterCAirways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophilsThorax1996512672718779129
   PubMed Web of Science ®Google Scholar
• FabbriLMRomagnoliMCorbettaLDifferences in airway inflammation in patients with chronic fixed airflow obstruction due to asthma or chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200316741842412426229
   PubMed Web of Science ®Google Scholar
• BarrechegurenMEsquinasCMiravitllesMThe asthma COPD overlap syndrome (ACOS). Opportunities and challengesCurr Opin Pulm Med201521747925405671
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol20124833133722341911
   PubMed Web of Science ®Google Scholar
• ChristensonSASteilingKvan den BergeMAsthma-COPD overlap: clinical relevance of genomic signatures of Type 2 inflammation in COPDAm J Respir Crit Care Med201519175876625611785
   PubMed Web of Science ®Google Scholar
• MiravitllesMSorianoJBAncocheaJCharacterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health statusRespir Med20131071053106023597591
   PubMed Web of Science ®Google Scholar
• BarrechegurenMRoman-RodriguezMMiravitllesMIs a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome (ACOS) in a patient with COPD?Int J Chron Obstruct Pulmon Dis2015101745175226366067
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBTORCH InvestigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• Alcázar NavarreteBCasanovaCMiravitllesMDocumento de consenso sobre el uso adecuado de los corticoides inhalados en la EPOC Study GroupCorrect use of inhaled corticosteroids in chronic obstructive pulmonary disease: a consensus documentArch Bronconeumol20155119319825540900
   PubMed Web of Science ®Google Scholar
• LeighRPizzichiniMMMorrisMMStable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEur Respir J20062796497116446316
   PubMed Web of Science ®Google Scholar
• KitaguchiYKomatsuYFujimotoKSputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthmaInt J Chron Obstruct Pulmon Dis2012728328922589579
   PubMed Web of Science ®Google Scholar
• van der ValkPMonninkhofEvan der PalenJEffect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE studyAm J Respir Crit Care Med20021661358136312406823
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWISDOM InvestigatorsWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med20143711285129425196117
   PubMed Web of Science ®Google Scholar
• MartinezFJCalverleyPMGoehringUMEffect of roflumilast on exacerbations in patients with severe chronic pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomized controlled trialLancet201538585786625684586
   PubMed Web of Science ®Google Scholar
• Muñoz-EsquerreMDiez-FerrerMMontónCRoflumilast added to triple therapy in patients with severe COPD: a real life studyPulm Pharmacol Ther201530162125445930
   PubMed Web of Science ®Google Scholar
• van RanstDStoopWAMeijerJWReduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation programInt J Chron Obstruct Pulmon Dis201491059106725336938
   PubMed Web of Science ®Google Scholar
• HuertasDLópez-SánchezMMateuLResults of a pulmonary rehabilitation program (PRP) in COPD patients: differences in outcomes according to currently 2011 GOLD groupsEur Respir J201444Suppl 58630
   Google Scholar
• Garcia-RioFRojoBCasitasRPrognostic value of the objective measurement of daily physical activity in patients with COPDChest201214233834622281798
   PubMed Web of Science ®Google Scholar
• MarinAGarcia-AymerichJSauledaJPAC-COPD Study GroupEffect of bronchial colonisation on airway and systemic inflammation in stable COPDCOPD2012912113022458940
   PubMedGoogle Scholar
• Martínez-GarcíaMAde la Rosa CarrilloDSoler-CataluñaJJPrognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318782383123392438
   PubMed Web of Science ®Google Scholar
• SmithIEJurriaansEDiederichSChronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chestThorax1996519149188984702
   PubMed Web of Science ®Google Scholar
• VendrellMde GraciaJOlveiraCDiagnóstico y tratamiento de las bronquiectasias [Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery]Arch Bronconeumol200844629640 Spanish19007570
   PubMed Web of Science ®Google Scholar
• RenomFYáñezAGarauMPrognosis of COPD patients requiring frequent hospitalization: role of airway infectionRespir Med201010484084820106648
   PubMed Web of Science ®Google Scholar
• AlmagroPSalvadóMGarcia-VidalCPseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary diseaseRespiration201284364321996555
   PubMed Web of Science ®Google Scholar
• MiravitllesMMonsóEMensaJAntimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statementArch Bronconeumol20084410010818361876
   PubMed Web of Science ®Google Scholar
• GallegoMPomaresXEspasaMPseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factorsBMC Pulm Med20141410324964956
   PubMed Web of Science ®Google Scholar
• MurphyTFBrauerALEschbergerKPseudomonas aeruginosa in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817785386018202344
   PubMed Web of Science ®Google Scholar
• MillaresLFerrariRGallegoMBronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosaEur J Clin Microbiol Infect Dis2014331101111124449346
   PubMed Web of Science ®Google Scholar
• Dal NegroRMichelettoCTognellaSTobramycin nebulizer solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammationAdv Ther2008251019103018821068
   PubMed Web of Science ®Google Scholar
• ManuelMJMuñoz-EzquerreMLópez-SánchezMAdherencia y efectividad en el control de exacerbaciones en pacientes con EPOC grave bajo el tratamiento con colimicina inhalada (Promixin®) en dispositivo I-neb [Effectiveness and adherence of inhaled colymycin in I-neb device (Promixin®) for control of exacerbations in severe COPD patients]Arch BronconeumolIn: 46th National Congress Spanish Society of Pulmonology and Thoracic Surgery2012 Spanish
   Google Scholar
• Perez-PadillaRde la Rosa-ZamboniDPonce de LeonSPneumonia and respiratory failure from swine-origin influenza A (H1N1) in MexicoN Engl J Med200936168068919564631
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish guideline for COPD (GesEPOC). Update 2014Arch Bronconeumol201450Suppl 111624507959
   PubMed Web of Science ®Google Scholar
• GómezJBañosVSimarroEEstudio prospectivo y comparativo (1994–1998) sobre la influencia del tratamiento corto profiláctico con azitromicina en pacientes con EPOC evolucionada [Prospective, comparative study (1994–1998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD]Rev Esp Quimioterap200013379383 Spanish
   PubMedGoogle Scholar
• SuzukiTYanaiMYamayaMErythromycin and common cold in COPDChest200112073073311555501
   PubMed Web of Science ®Google Scholar
• SeemungalTAWilkinsonTMHurstJRLong-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med20081781139114718723437
   PubMed Web of Science ®Google Scholar
• PomaresXMontónCEspasaMLong-term azithromycin therapy in patients with severe COPD and repeated exacerbationsInt J Chron Obstruct Pulmon Dis2011644945622003290
   PubMed Web of Science ®Google Scholar
• HeZYOuLMZhangJQEffect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary diseaseRespiration20108044545220881376
   PubMed Web of Science ®Google Scholar
• BlasiFBonardiDAlibertiSLong-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomyPulm Phamacol Ther201023200207
   PubMed Web of Science ®Google Scholar
• AllegraLBlasiFDianoPSputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary diseaseRespir Med20059974274715878491
   PubMed Web of Science ®Google Scholar
• EllerJEdeASchabergTInfective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung functionChest1998113154215489631791
   PubMed Web of Science ®Google Scholar
• LodeHAlleweltMBalkSA prediction model for bacterial etiology in acute exacerbations of COPDInfection20073514314917565454
   PubMed Web of Science ®Google Scholar
• MonsóEGarcía-AymerichJSolerNBacterial infection in exacerbated COPD with changes in sputum characteristicsEpidemiol Infect200313179980412948381
   PubMed Web of Science ®Google Scholar
• García-VidalCAlmagroPRomaníVPseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective studyEur Respir J2009341072107819386694
   PubMed Web of Science ®Google Scholar